Research
What Is CAR T-Cell Therapy? The Treatment Making Headlines, Explained
CAR T-cell therapy uses a person's own immune cells to fight cancer. Here's what it is, which cancers it treats, and what to keep in mind.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What people see in the news
CAR T-cell therapy shows up in the news as a near-miraculous cancer treatment — a "living drug" made from a patient's own cells that can wipe out advanced cancers. The excitement is real, and so are the limits worth understanding.
What it actually means
According to the National Cancer Institute, CAR T-cell therapy is a form of immunotherapy that uses a patient's own T cells — immune cells that normally hunt diseased cells — re-engineered to attack cancer. NCI describes the process: doctors collect the patient's blood and separate out T cells, which are sent to a lab and genetically modified to make special surface proteins called chimeric antigen receptors (CARs). These CARs help the cells recognize and latch onto proteins on cancer cells. The modified cells are multiplied into the hundreds of millions and infused back into the patient, where they continue to expand and target the cancer.
The FDA approved the first CAR T-cell therapy in 2017, for children with a form of acute lymphoblastic leukemia. Since then, NCI notes, others have been approved for adults with blood cancers such as certain lymphomas and multiple myeloma. In some people with very advanced disease, these therapies can eliminate cancer for long periods — and in some cases appear to cure it.
NCI is also candid that CAR T-cell therapy doesn't work for everyone and can cause serious side effects. Two of particular concern are cytokine release syndrome (which can cause high fevers and dangerous drops in blood pressure) and neurologic effects such as confusion. These are managed in specialized centers, and NCI notes that treatments exist to control them.
What this does and doesn't change
- CAR T-cell therapy is mainly for certain blood cancers — leukemias, lymphomas, and multiple myeloma. NCI notes that progress on solid tumors (like breast or colon cancer) has lagged and is still largely research.
- It is often used after other treatments have stopped working, though its use earlier in treatment is being studied.
- Making the therapy is complex and individualized. NCI notes the full process typically takes about three to five weeks.
- It requires care at experienced centers because of the risk of serious side effects.
Questions to ask a healthcare team
- Is CAR T-cell therapy an option for my type of cancer?
- What are the benefits and risks in my situation?
- Would I need to travel to a specialized center?
- Are there clinical trials I might be eligible for?
Understanding your own risk factors and getting recommended screenings remains the foundation of cancer prevention, and our free screening check-up tool can help you see what applies to you. Learning how a headline treatment actually works makes the news easier to follow, and free, plain-language cancer education helps more people do exactly that.